Compare AIOT & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIOT | EVMN |
|---|---|---|
| Founded | 1993 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.4M | 474.7M |
| IPO Year | 2024 | 2025 |
| Metric | AIOT | EVMN |
|---|---|---|
| Price | $2.83 | $8.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $10.33 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 1.2M | 661.7K |
| Earning Date | 06-15-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.12 | ★ 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $443,777,000.00 | $13,000,000.00 |
| Revenue This Year | $24.46 | N/A |
| Revenue Next Year | $9.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 22.42 | ★ 85.71 |
| 52 Week Low | $2.78 | $8.25 |
| 52 Week High | $5.88 | $33.20 |
| Indicator | AIOT | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 26.60 |
| Support Level | N/A | N/A |
| Resistance Level | $3.12 | $13.35 |
| Average True Range (ATR) | 0.09 | 0.68 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 5.17 | 5.00 |
PowerFleet Inc provides artificial intelligence of things (AIoT) software-as-a-service (SaaS) solutions for the mobile asset industry globally. The company's Unity data highway and AIoT ecosystem ingest data from multiple data sources and deliver actionable insights through a Software-as-a-Service (SaaS) platform, for improving the performance of the mobile asset (such as forklifts, tuggers, trucks, rental cars, etc.), the individual in charge, and the business process. Its offerings include a variety of IoT devices integrated with software solutions for asset tracking, operational monitoring, AI-powered video safety, compliance management, and analytics under brands such as Powerfleet, Pointer, Cellocator, MiX by Powerfleet, and Fleet Complete. The company's key market is North America.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.